AL
VNDA icon

AJO LP’s Vanda Pharmaceuticals VNDA Stock Holding History

AJO LP’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,411
Closed -$61K – 646
2020
Q3 		$61K Sell
6,411
-20,993
-77% -$224K ﹤0.01% 653
2020
Q2 		$313K Sell
27,404
-2,504
-8% -$28.4K ﹤0.01% 562
2020
Q1 		$309K Buy
29,908
+12,894
+76% +$160K ﹤0.01% 533
2019
Q4 		$279K Buy
+17,014
New +$257K ﹤0.01% 492
2018
Q3 		– Sell
-72,805
Closed -$1.39M – 727
2018
Q2 		$1.39M Sell
72,805
-181,825
-71% -$3.04M 0.01% 487
2018
Q1 		$4.29M Sell
254,630
-143,717
-36% -$2.41M 0.02% 354
2017
Q4 		$6.05M Sell
398,347
-104,908
-21% -$1.56M 0.03% 299
2017
Q3 		$9.01M Sell
503,255
-38,672
-7% -$647K 0.04% 242
2017
Q2 		$8.83M Buy
541,927
+262,833
+94% +$3.79M 0.04% 230
2017
Q1 		$3.91M Sell
279,094
-525,112
-65% -$7.48M 0.02% 309
2016
Q4 		$12.8M Sell
804,206
-71,114
-8% -$1.14M 0.05% 188
2016
Q3 		$14.6M Buy
875,320
+679,405
+347% +$9.15M 0.06% 187
2016
Q2 		$2.19M Buy
+195,915
New +$1.9M 0.01% 333

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AJO LP's VNDA Position: Q4 2020 in Review

AJO LP sold out of Vanda Pharmaceuticals (VNDA) in Q4 2020, closing a stake of 6,411 shares — an estimated $61K sold.

AJO LP first reported a position in VNDA in Q2 2016 and held it in 13 quarters. The position peaked at $14.6M in Q3 2016. 178 funds tracked by Wall St. Rank hold VNDA as of Q4 2020.

  • AJO LP reported no remaining Vanda Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • AJO LP sold 6,411 Vanda Pharmaceuticals shares in Q4 2020, an estimated $61K.
  • AJO LP first reported a position in Vanda Pharmaceuticals in Q2 2016 and held it in 13 quarters.
  • AJO LP's Vanda Pharmaceuticals position peaked at $14.6M in Q3 2016.
  • 178 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.